Dendritic Cells Transfected with Cytopathic Self-Replicating RNA Induce Crosspriming of CD8+ T Cells and Antiviral Immunity

Immunity

Volumn 20, Issue 1, 2004, Pages 47-58

  Racanelli, Vito ^a   Behrens, Sven Erik ^b,c   Aliberti, Julio ^a,d   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c FOX CHASE CANCER CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA ANTIGEN; VIRUS ANTIGEN; VIRUS RNA; VIRUS VACCINE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL TRANSFER; CELLULAR IMMUNITY; CYTOPATHOGENIC EFFECT; DENDRITIC CELL; GENETIC TRANSFECTION; HEPATITIS C VIRUS; IMMUNOGENICITY; IN VIVO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PATHOGENESIS; PESTIVIRUS; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; SPLEEN; T LYMPHOCYTE; TRANSGENIC MOUSE; VACCINIA VIRUS; VIRUS CHARACTERIZATION; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 1642538454     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00353-4     Document Type: Article

References (53)

1. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998;86-89.
2. Bain C., Fatmi A., Zoulim F., Zarski J.P., Trepo C., Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology. 120:2001;512-524.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
4. Barnaba V., Franco A., Alberti A., Benvenuto R., Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I restricted, exogenous antigen specific T lymphocytes. Nature. 345:1990;258-260.
5. Bartenschlager R., Ahlborn-Laake L., Mous J., Jacobsen H. Kinetic and structural analyses of hepatitis C virus polyprotein processing. J. Virol. 68:1994;5045-5055.
6. Behrens S.E., Grassmann C.W., Thiel H.J., Meyers G., Tautz N. Characterization of an autonomous subgenomic pestivirus RNA replicon. J. Virol. 72:1998;2364-2372.
7. Berd D. Autologous, hapten-modified vaccine as a treatment for human cancers. Vaccine. 19:2001;2565-2570.
8. Bevan M.J. Antigen recognition. Class discrimination in the world of immunology. Nature. 325:1987;192-194.
9. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:1999;821-829.
10. Davis G.L., Albright J.E., Cook S.F., Rosenberg D.M. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 9:2003;331-338.
11. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:2000;1685-1696.
12. Dhodapkar M.V., Steinman R.M., Sapp M., Desai H., Fossella C., Krasovsky J., Donahoe S.M., Dunbar P.R., Cerundolo V., Nixon D.F., Bhardwaj N. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J. Clin. Invest. 104:1999;173-180.
13. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga A., Santantonio T., Jung M.-C., Eichenlaub D., Pape G.R. Possible mechanism involving T lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
14. Drexler I., Staib C., Kastenmuller W., Stevanovic S., Schmidt B., Lemonnier F.A., Rammensee H.G., Busch D.H., Bernhard H., Erfle V., Sutter G. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines. Proc. Natl. Acad. Sci. USA. 100:2003;217-222.
15. Freigang S., Egger D., Bienz K., Hengartner H., Zinkernagel R.M. Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming. Proc. Natl. Acad. Sci. USA. 100:2003;13477-13482.
16. Grassmann C.W., Isken O., Tautz N., Behrens S.E. Genetic analysis of the pestivirus nonstructural coding region. defects in the NS5A unit can be complemented in trans J. Virol. 75:2001;7791-7802.
17. Guermonprez P., Valladeau J., Zitvogel L., Thery C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:2002;621-667.
18. Gurunathan S., Wu C.Y., Freidag B.L., Seder R.A. DNA vaccines. a key for inducing long-term cellular immunity Curr. Opin. Immunol. 12:2000;442-447.
19. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:2001;47-64.
20. Huang A.Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:1994;961-965.
21. Inaba K., Turley S., Yamaide F., Iyoda T., Mahnke K., Inaba M., Pack M., Subklewe M., Sauter B., Sheff D.et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J. Exp. Med. 188:1998;2163-2173.
22. Khromykh A.A. Replicon-based vectors of positive strand RNA viruses. Curr. Opin. Mol. Ther. 2:2000;555-569.
23. Kleindienst P., Brocker T. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo. J. Immunol. 170:2003;2817-2823.
24. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA. 90:1993;4942-4946.
25. Leitner W.W., Hwang L.N., deVeer M.J., Zhou A., Silverman R.H., Williams B.R., Dubensky T.W., Ying H., Restifo N.P. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 9:2003;33-39.
26. Lindenbach B.D., Rice C.M. Flaviviridae. the viruses and their replication Knipe D., Howley P., Griffin D., Lamb R., Martin M., Roizman B., Straus S. Fields Virology. 2001;991-1041 Lippincott Williams & Wilkins, Philadelphia, PA.
27. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 285:1999;110-113.
28. Major M.E., Rehermann B., Feinstone S.M. Hepatitis C viruses. Knipe D.M., Howley P.M., Chanock R.M., Monath T.P., Roizman B., Straus S.E. Fields Virology. 2001;1127-1161 Lippincott-Raven Publishers, Philadelphia.
29. Meyers G., Tautz N., Becher P., Thiel H.J., Kummerer B.M. Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs. J. Virol. 70:1996;8606-8613.
30. Mueller S.N., Jones C.M., Smith C.M., Heath W.R., Carbone F.R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195:2002;651-656.
31. Nascimbeni M., Mizukoshi E., Bosmann M., Major M., Mihalik K., Rice C., Feinstone S., Rehermann B. Kinetics of CD4+ and CD8+ memory T cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J. Virol. 77:2003;4781-4793.
32. Newberg M.H., Smith D.H., Haertel S.B., Vining D.R., Lacy E., Engelhard V.H. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. J. Immunol. 156:1996;2473-2480.
33. Okada N., Saito T., Masunaga Y., Tsukada Y., Nakagawa S., Mizuguchi H., Mori K., Okada Y., Fujita T., Hayakawa T.et al. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells. Cancer Res. 61:2001;7913-7919.
34. Pooley J.L., Heath W.R., Shortman K. Cutting edge. intravenous soluble antigen is presented to CD4 T cells by CD8-dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells J. Immunol. 166:2001;5327-5330.
35. Ramirez M.C., Sigal L.J. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 169:2002;6733-6742.
36. Rock K.L., Gamble S., Rothstein L. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science. 249:1990;918-921.
37. Saeboe-Larssen S., Fossberg E., Gaudernack G. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J. Immunol. Methods. 259:2002;191-203.
38. Schuler G., Schuler-Thurner B., Steinman R.M. The use of dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 15:2003;138-147.
39. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:1997;2723-2730.
40. Shi Y., Evans J.E., Rock K.L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 425:2003;516-521.
41. Shoukry N., Grakoui A., Houghton M., Chien D., Ghrayeb J., Reimann K., Walker C. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197:2003;1645-1655.
42. Sigal L.J., Crotty S., Andino R., Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature. 398:1999;77-80.
43. Steinman R.M., Hawiger D., Liu K., Bonifaz L., Bonnyay D., Mahnke K., Iyoda T., Ravetch J., Dhodapkar M., Inaba K.et al. Dendritic cell function in vivo during the steady state. a role in peripheral tolerance Ann. N Y Acad. Sci. 987:2003;15-25.
44. Takaki A., Wiese M., Maertens G., Depla E., Seifert U., Liebetrau A., Miller J.L., Manns M.P., Rehermann B. Cellular immune responses persist, humoral responses decrease two decades after recovery from a single source outbreak of hepatitis C. Nat. Med. 6:2000;578-582.
45. Tautz N., Harada T., Kaiser A., Rinck G., Behrens S., Thiel H.J. Establishment and characterization of cytopathogenic and noncytopathogenic pestivirus replicons. J. Virol. 73:1999;9422-9432.
46. Thiel H., Plagemann P., Moenning V. Pestiviruses. Knipe D., Howley P., Channock R., Melnick J., Monath T., Roizman B., Straus S. Fields Virology. 1996;1059-1074 Lippincott-Raven, Philadelphia, PA.
47. Thimme R., Oldach D., Chang K.M., Steiger C., Ray S.C., Chisari F.V. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:2001;1395-1406.
48. van den Hoff M.J., Moorman A.F., Lamers W.H. Electroporation in 'intracellular' buffer increases cell survival. Nucleic Acids Res. 20:1992;2902.
49. Wedemeyer H., Gagneten S., Davis A., Bartenschlager R., Feinstone S., Rehermann B. Oral immunization with HCV-NS3-transformed salmonella. induction of HCV-specific CTL in a transgenic mouse model Gastroenterology. 121:2001;1158-1166.
50. Wiskerchen M., Belzer S.K., Collett M.S. Pestivirus gene expression. the first protein product of the bovine viral diarrhea virus large open reading frame, p20, possesses proteolytic activity J. Virol. 65:1991;4508-4514.
51. Wolk B., Sansonno D., Krausslich H.G., Dammacco F., Rice C.M., Blum H.E., Moradpour D. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J. Virol. 74:2000;2293-2304.
52. Ying H., Zaks T.Z., Wang R.F., Irvine K.R., Kammula U.S., Marincola F.M., Leitner W.W., Restifo N.P. Cancer therapy using a self-replicating RNA vaccine. Nat. Med. 5:1999;823-827.
53. Zinkernagel R.M. On cross-priming of MHC class I-specific CTL. rule or exception? Eur. J. Immunol. 32:2002;2385-2392.